To contact us phone:  +61 2 9385 7517

BOARD

Professor Klaus Schindhelm BE PhD (Chair)

Professor Klaus Schindhelm is Senior Vice President Global Applied Research of ResMed Ltd; and Professor of the Graduate School of Biomedical Engineering, University of New South Wales (UNSW). Professor Schindhelm graduated with a BE in Chemical Engineering in 1975 and a PhD in 1978 and was Alexander von Humboldt Fellow, in Nephrology, Medizinische Hochschule Hannover, West Germany.

He then joined UNSW, holding a number of positions including as Head of the Graduate School of Biomedical Engineering. In 1998, Klaus became the Vice President, Product Development, and then Senior Vice President, Operations, of ResMed Ltd, a leading Australian biomedical company. He has made significant contributions to the international biomedical community as a Member of the Governing Council, International Federation for Medical and Biological Engineering and Board Member of the Australian Nuclear Science and Technology Organisation and Member of the Therapeutic Goods Committee and Medical Device Evaluation Committee, Australian Therapeutic Goods Administration.

Klaus is also Chairman of the National Committee on Biomedical Engineering, Institution of Engineers and Founding Chairman, Board of College of Biomedical Engineers.


Jenni Lightowlers, LLM LLB (Hons) BA DipEd

A founding partner of Francis Abourizk Lightowlers (FAL), Jenni has worked closely with the Brien Holden Vision Institute (formerly the Institute for Eye Research) and Brien Holden Vision Institute, Public Health (formerly International Centre for Eyecare Education) for a number of years. She is also a director of Vision CRC Limited, which has worked closely with the BHV group in developing innovative technologies and providing public health initiatives in the field of vision correction.

Jenni is Deputy Chancellor of Deakin University, Chair of the University’s Legislation Committee and a member of the Law Faculty Advisory Board. Jenni is also a member of the Australian Institute of Company Directors, the Licensing Executives Society and the Intellectual Property Society of Australia Inc.  She is also a director of INAP Limited, a consortia of international mining companies based out of Australia. In 2015 Jenni was awarded the Australian Life Sciences lawyer of the year award.

Jenni’s interest in not-for-profit organisations has resulted in her providing support to a large number of Cooperative Research Centres and their participants, providing advice on structuring, taxation, corporate management, directors’ duties, intellectually property management, spin-off companies and venture capital funding. She is also engaged with higher education providers in the Pacific region, providing support on governance, policy and strategic issues. 


Ms Yvette Waddell, MBA

Yvette Waddell is Chief Operating Officer (COO) at the Brien Holden Vision Institute and has been involved with ophthalmic research and education for more than 20 years. As Chief Commercial Officer for Brien Holden Vision Institute, Yvette holds responsibility for commercial and intellectual property and business development strategies. In her executive management position, Ms Waddell oversees legal, finance and other operational sections.

She is CEO of Brien Holden Vision Diagnostics, which specialises in equipment that measures key properties of the eye to identify and monitor ocular and systemic disease. Ms Waddell also holds Directorships with the Australia, China, India and US commercial subsidiaries of Brien Holden Vision. Ms Waddell was General Manager (GM), Deputy CEO and is now Interim CEO and Director of Vision CRC, one of Australia’s most successful Cooperative Research Centres. From 2008, Ms Waddell was Chief Executive Officer of Viscorp Pty Ltd, the commercialisation company established by Vision CRC partners to manage and commercialise intellectual property generated by Vision CRC programs.

Copyright © 2016 VisionCRC. All Rights Reserved.